Delivery Order SPE2DB24D9803-SPE2DB25FJSCV

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,082.93, is for the delivery of 4,568,187,298 units of the contraceptive implant Nexplanon. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November...
This is a $6,291.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,556,217,484 units of the contraceptive implant NEXPLANON 68 MG and has a completion date of February 28, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,024.40 contract is for the delivery of 4,560,374,802 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $4,165.86, is for the delivery of 4,568,143,402 units of the contraceptive implant device Nexplanon. The award has no set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. This IDC enables DLA to issue delivery orders for a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,573.45, is for the supply of Nexplanon 68 mg contraceptive implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue firm...
This is a $5,717.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is for the procurement of 4,564,764,375 units of the contraceptive implant Nexplanon 68 mg, with a period of performance through June 14, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,024.40 contract is for the delivery of 4,562,125,118 units of Nexplanon 68 MG implants, a contraceptive product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31,...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $32,819.52 and covers the delivery of 4,562,313,640 units of the contraceptive implant NEXPLANON 68 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $4,288.14 and covers the delivery of 68 mg Nexplanon contraceptive implants. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a wide range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 contract is for the delivery of Nexplanon 68 mg implants, a contraceptive product, to support the recurring medical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with...
  • SPE2DB24D9803
    Indefinite Delivery Contract
  • SPE2DB24D9803-SPE2DB25FJSCV
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $6,943.10, is for the delivery of 4,567,991,932 units of the contraceptive implant Nexplanon 68 mg. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract does not have a set-aside designation.

Generated 7/17/25, 2:17 PM